fashion -WSS

fashion

author：leisure time 2025-09-06 01:41:18 - browse：9

JOSEPH PREZIOSO/AFP via Getty Images

Late-stage trial results for a pain medication developed by Vertex Pharmaceuticals reinforced experts’ sense that the drug was both safe and offered modest pain relief. But the findings also prompted fresh debate on Tuesday about how widely used the therapy would be should it win regulatory approval.

The company reported that its small molecule drug, VX-548, outperformed placebo in a pair of pain relief trials that recruited patients who had gotten an abdominoplasty (tummy tuck) or bunion surgery. The study also found that the drug was generally safe, with fewer patients on the medication reporting adverse events than those who had taken a placebo. But there was a catch: VX-548 didn’t outperform a combination of acetaminophen and the opioid hydrocodone, a key secondary endpoint. And in the bunionectomy study, the opioid comparator beat VX-548 on pain relief.

“While this study was not explicitly designed to test VX-548 vs. the opioid comparator, this may complicate the prescribing decision in the acute setting, where patients often take a short course of treatment and efficacy is a primary consideration,” Stifel market analyst Paul Matteis wrote in a note to investors, adding that results from three Phase 3 studies were positive overall.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Pediatricians' group reaffirms support for gender

explore

focus

WSS

Life sciences investors close nearly $6 billion in new funds

Parkland mass shooting to be reenacted for lawsuit

Explaining an after

All of Us, NIH's precision medicine initiative, gets a big boost

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

Scientists find bacteria from stomach of ancient iceman

focus

fashion

explore

Jerome Adams on the need for new antivirals for Covid

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Peter Hotez and the public health issue of online harassment

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Moonlake's readout produced a cash windfall. Risks remain

Medicare must police algorithms in Medicare Advantage, Dems say

BioMarin wins approval for gene therapy to treat hemophilia A

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Heart attack and stroke risk calculators need revising

Kidney transplant patients stopped immunosuppressants in trial

knowledge

How to convince healthy people to buy insurance

DeepMind touts AlphaFold's new skills as protein folding AI models face off

How neuroscience research could help beat back brain cancer

Prime Medicine says its gene editing passes test in monkeys

Jesse Tyler Ferguson makes friendship bracelets for Taylor Swift's Eras Tour

Pediatricians' group reaffirms support for gender

explore

knowledge

focus

hotspot